NCT06407219

Brief Summary

Early use of robotic gait trainers have shown many benefits, however why these benefits occur and how to maximize them is unknown. There are a few options for how a robotic gait trainer can be used, however, there is not much understanding of how these options impact rehabilitation and compensate for impairments. The investigators aim to evaluate the impacts of as single session of Trexo robotic gait training and the impact of different modes of the Trexo robotic gait trainer. The investigators will evaluate how the different settings impact things like physical activity, walking, brain activity, spasticity, and fatigue. Investigators will arrange for a familiarity and fitting session to start, so that study team members can fit the participant to the Trexo and so that participants can become familiar with the feeling of using the Trexo robotic gait trainer. After the initial fitting sessions, follow up sessions will be completed to evaluate different settings on the Trexo, for example in "endurance" mode (where the robot completes the movements for the participant) and in "strength" mode (where the robot requires some assistance from the participant). Investigators may also test different fitting settings, for example with and without the supportive seat in the Trexo. Only three visits are required (one fitting/familiarity session and two testing sessions), however participants and/or their families may choose to complete more testing sessions if they want to assess other aspects of the training. For example, if the first two testing sessions assessed physical activity, participants and their families may choose to return for further sessions to assess brain activity. The aim of the study is to determine how robot assisted gait training impacts rehabilitation and compensates for impairments, as well as to provide suggestions on how the robotic gait trainer might be improved or modified. This study is exploratory to find out more about how these robotic gait trainers, specifically the Trexo, impacts various aspects of rehabilitation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started Mar 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Mar 2022Dec 2026

Study Start

First participant enrolled

March 14, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 14, 2022

Completed
2.1 years until next milestone

First Posted

Study publicly available on registry

May 9, 2024

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

February 6, 2026

Status Verified

February 1, 2026

Enrollment Period

4.7 years

First QC Date

April 14, 2022

Last Update Submit

February 3, 2026

Conditions

Keywords

Robot Assisted Gait TrainingTrexoRehabilitation

Outcome Measures

Primary Outcomes (1)

  • Change in Heart Rate Response to Exercise

    We will use the collected heart rate as well as an estimated maximum heart rate (208-0.7\*age) to determine the heart rate reserve (estimated maximum heart rate minus measured resting heart rate). Once the heart rate reserve has been calculated, the measured heart rate throughout the session will be used to determine how much time the participant spent above 40% of their heart rate reserve.

    Through study completion, an average of 4 weeks.

Secondary Outcomes (9)

  • Duration of Exercise Session

    Through study completion, an average of 4 weeks.

  • Total Number of Steps Taken

    Through study completion, an average of 4 weeks.

  • Average Number of Steps per Minute

    Through study completion, an average of 4 weeks.

  • Participant or Proxy Report of Rating of Perceived Exertion (RPE)

    Through study completion, an average of 4 weeks.

  • Brain Region Activation

    Through study completion, an average of 4 weeks.

  • +4 more secondary outcomes

Study Arms (2)

Passive "Endurance"

ACTIVE COMPARATOR

Participants will complete a training session using the Trexo robotic gait trainer in the "endurance" mode with a fixed gait pattern regardless of the participant's activity.

Device: Robot Assisted Gait Training

Voluntary activity "Strength"

ACTIVE COMPARATOR

Participants will complete a training session using the Trexo robotic gait trainer in the "strength" mode where the gait pattern is impacted by the participant's activity

Device: Robot Assisted Gait Training

Interventions

The Trexo robotic gait trainer will be used to facilitate physical activity in people who cannot walk independently, either at all or without the use of assistive gait aids (ie. walkers or canes). Session length will be determined by the participant's perceived fatigue level (ie. the session will run until the participant feels they want to or need to stop), and will not exceed 1 hour of training time.

Passive "Endurance"Voluntary activity "Strength"

Eligibility Criteria

Age4 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Able to fit into the Trexo robotic gait trainer (\<150 lbs., \<5'7").
  • Has impaired ability to walk due to a neurological or muscular disorder.

You may not qualify if:

  • \>150 lbs.
  • \>5'6" tall
  • Medical contraindication to weight bearing (ie. recent orthopedic surgery)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alberta Children's Hospital

Calgary, Alberta, T3B 6A8, Canada

RECRUITING

MeSH Terms

Conditions

Cerebral PalsyDevelopmental Disabilities

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurodevelopmental DisordersMental Disorders

Study Officials

  • Elizabeth G Condliffe, MD, PhD

    University of Calgary

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will not know which mode they are completing on which day. Caregivers may be told if they ask, and investigators and outcome investigators will know the randomization.
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: This study is a randomized cross-over design, where participants will complete a training session in both the endurance mode and the strength mode of the Trexo robotic gait trainer. The session completed first will be randomized.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Clinical Professor

Study Record Dates

First Submitted

April 14, 2022

First Posted

May 9, 2024

Study Start

March 14, 2022

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

February 6, 2026

Record last verified: 2026-02

Locations